Form 10 Explorer
10-K/A
Annual Report
DAY ONE BIOPHARMACEUTICALS, INC.

DAWN

NASDAQ

CIK: 1845337

File #: 001-40431

Period End: Dec 31, 2025

Fiscal Year: 2025

View on EDGAR
Balance Sheet
4 line items
XBRL
ItemJun 30, 2025
Current assets:
Liabilities and stockholders' equity
Current liabilities:
Stockholders' equity
DAY ONE BIOPHARMACEUTICALS, INC. (DAWN) — 10-K/A Filing | Form 10 Explorer